这是一篇来自已证抗体库的有关人类 PAI-1 (PAI-1) 的综述,是根据26篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合PAI-1 抗体。
PAI-1 同义词: PAI; PAI-1; PAI1; PLANH1; plasminogen activator inhibitor 1; endothelial plasminogen activator inhibitor; serine (or cysteine) proteinase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1; serpin E1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1

艾博抗(上海)贸易有限公司
兔 多克隆
  • 免疫印迹; 猪; 图 5
艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab66705)被用于被用于免疫印迹在猪样本上 (图 5). J Am Heart Assoc (2016) ncbi
小鼠 单克隆(1D5)
  • 免疫印迹; 小鼠; 图 1
艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab125687)被用于被用于免疫印迹在小鼠样本上 (图 1). Iran J Basic Med Sci (2016) ncbi
兔 多克隆
  • 免疫印迹; 人类; 图 1
艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab66705)被用于被用于免疫印迹在人类样本上 (图 1). Sci Rep (2015) ncbi
山羊 多克隆
  • 免疫印迹; 人类; 图 1a
艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab31280)被用于被用于免疫印迹在人类样本上 (图 1a). Oncotarget (2015) ncbi
小鼠 单克隆(1D5)
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab125687)被用于被用于免疫印迹在人类样本上浓度为1:1000. FEBS Lett (2015) ncbi
兔 多克隆
  • 免疫组化; 人类; 1:1000
艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab66705)被用于被用于免疫组化在人类样本上浓度为1:1000. FEBS Lett (2015) ncbi
小鼠 单克隆(1D5)
  • 免疫印迹; 人类; 1:2000; 图 4
艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab125687)被用于被用于免疫印迹在人类样本上浓度为1:2000 (图 4). Mol Med Rep (2015) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
艾博抗(上海)贸易有限公司PAI-1抗体(Abcam, ab66705)被用于被用于免疫印迹在人类样本上浓度为1:1000. J Mol Endocrinol (2014) ncbi
圣克鲁斯生物技术
小鼠 单克隆(C-9)
  • 免疫印迹; 人类; 图 2a
圣克鲁斯生物技术PAI-1抗体(Santa Cruz, sc-5297)被用于被用于免疫印迹在人类样本上 (图 2a). Sci Rep (2017) ncbi
小鼠 单克隆(C-9)
  • 免疫印迹; 人类; 1:500; 图 2c
圣克鲁斯生物技术PAI-1抗体(SantaCruz, sc-5297)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 2c). Oncol Lett (2016) ncbi
小鼠 单克隆(C-9)
  • 免疫细胞化学; 人类; 图 s1a
  • 免疫印迹; 人类; 图 3a
圣克鲁斯生物技术PAI-1抗体(Santa cruz, sc-5297)被用于被用于免疫细胞化学在人类样本上 (图 s1a) 和 被用于免疫印迹在人类样本上 (图 3a). Cell Cycle (2015) ncbi
小鼠 单克隆(C-9)
  • 免疫细胞化学; 猪; 图 1
圣克鲁斯生物技术PAI-1抗体(Santa cruz, sc-5297)被用于被用于免疫细胞化学在猪样本上 (图 1). PLoS ONE (2015) ncbi
小鼠 单克隆(C-9)
  • 免疫印迹; 人类
圣克鲁斯生物技术PAI-1抗体(Santa Cruz Biotechnology, sc-5297)被用于被用于免疫印迹在人类样本上. J Biol Chem (2014) ncbi
小鼠 单克隆(C-9)
  • 免疫细胞化学; 人类; 1:100
圣克鲁斯生物技术PAI-1抗体(Santa Cruz, sc-5297)被用于被用于免疫细胞化学在人类样本上浓度为1:100. J Biol Chem (2013) ncbi
安迪生物R&D
山羊 多克隆
  • 免疫组化-石蜡切片; 人类
安迪生物R&DPAI-1抗体(R&D Systems, AF1786)被用于被用于免疫组化-石蜡切片在人类样本上. Breast Cancer Res (2014) ncbi
亚诺法生技股份有限公司
小鼠 单克隆(1D5)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 1a
  • 免疫印迹; 人类; 1:1000
亚诺法生技股份有限公司PAI-1抗体(Abnova, 1D5)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 1a) 和 被用于免疫印迹在人类样本上浓度为1:1000. Oncotarget (2015) ncbi
赛默飞世尔
小鼠 单克隆(1D5)
  • 免疫印迹; 人类; 1:600
赛默飞世尔PAI-1抗体(Zymed, 1D5)被用于被用于免疫印迹在人类样本上浓度为1:600. Tumour Biol (2012) ncbi
碧迪BD
小鼠 单克隆(41/PAI-1)
  • 其他; 人类; 图 4c
碧迪BDPAI-1抗体(BD Biosciences, 612024)被用于被用于其他在人类样本上 (图 4c). Cancer Cell (2018) ncbi
小鼠 单克隆(41/PAI-1)
  • reverse phase protein lysate microarray; 人类; 图 st6
碧迪BDPAI-1抗体(BD Biosciences, 612024)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 st6). Cancer Cell (2017) ncbi
小鼠 单克隆(41/PAI-1)
  • reverse phase protein lysate microarray; 人类; 图 3a
碧迪BDPAI-1抗体(BD Biosciences, 612024)被用于被用于reverse phase protein lysate microarray在人类样本上 (图 3a). Nature (2017) ncbi
小鼠 单克隆(41/PAI-1)
  • 免疫印迹; 人类; 图 7e
碧迪BDPAI-1抗体(BD Transduction Laboratories, 612024)被用于被用于免疫印迹在人类样本上 (图 7e). Oncogene (2017) ncbi
小鼠 单克隆(41/PAI-1)
  • 免疫印迹; 人类; 图 6b
碧迪BDPAI-1抗体(BD Transduction Laboratories, 612024)被用于被用于免疫印迹在人类样本上 (图 6b). Breast Cancer Res (2016) ncbi
小鼠 单克隆(41/PAI-1)
  • 免疫组化-石蜡切片; 人类; 1:200; 图 s1
碧迪BDPAI-1抗体(BD科学, P612024)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:200 (图 s1). BMC Cancer (2016) ncbi
小鼠 单克隆(41/PAI-1)
  • 免疫印迹; 人类; 1:5000
碧迪BDPAI-1抗体(BD Biosciences, 612025)被用于被用于免疫印迹在人类样本上浓度为1:5000. J Cell Physiol (2015) ncbi
小鼠 单克隆(41/PAI-1)
  • 免疫印迹; 人类; 图 11
碧迪BDPAI-1抗体(BD Transduction, 612025)被用于被用于免疫印迹在人类样本上 (图 11). Nucleic Acids Res (2015) ncbi
默克密理博中国
小鼠 单克隆
  • 其他; 人类; 图 s1
默克密理博中国PAI-1抗体(Calbiochem, IM29L-100UG)被用于被用于其他在人类样本上 (图 s1). Cell Chem Biol (2017) ncbi
兔 多克隆
  • 免疫印迹; 人类; 1:1000
默克密理博中国PAI-1抗体(Millipore, 09-726)被用于被用于免疫印迹在人类样本上浓度为1:1000. PLoS ONE (2015) ncbi
文章列表
  1. Ng P, Li J, Jeong K, Shao S, Chen H, Tsang Y, et al. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018;33:450-462.e10 pubmed 出版商
  2. Shah F, Stepan A, O Mahony A, Velichko S, Folias A, Houle C, et al. Mechanisms of Skin Toxicity Associated with Metabotropic Glutamate Receptor 5 Negative Allosteric Modulators. Cell Chem Biol. 2017;24:858-869.e5 pubmed 出版商
  3. Yan Y, Zhao W, Huang Y, Tong H, Xia Y, Jiang Q, et al. Loss of Polycomb Group Protein Pcgf1 Severely Compromises Proper Differentiation of Embryonic Stem Cells. Sci Rep. 2017;7:46276 pubmed 出版商
  4. Cherniack A, Shen H, Walter V, Stewart C, Murray B, Bowlby R, et al. Integrated Molecular Characterization of Uterine Carcinosarcoma. Cancer Cell. 2017;31:411-423 pubmed 出版商
  5. . Integrated genomic and molecular characterization of cervical cancer. Nature. 2017;543:378-384 pubmed 出版商
  6. Chan D, Hui W, Wang J, Yung M, Hui L, Qin Y, et al. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling. Oncogene. 2017;36:1404-1416 pubmed 出版商
  7. LAW M, Ferreira R, Davis B, Higgins P, Kim J, Castellano R, et al. CUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment. Breast Cancer Res. 2016;18:80 pubmed 出版商
  8. Ding Y, Zhang H, Lu A, Zhou Z, Zhong M, Shen D, et al. Effect of urokinase-type plasminogen activator system in gastric cancer with peritoneal metastasis. Oncol Lett. 2016;11:4208-4216 pubmed
  9. Eirin A, Ebrahimi B, Kwon S, Fiala J, Williams B, Woollard J, et al. Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular Hypertension. J Am Heart Assoc. 2016;5: pubmed 出版商
  10. Liang Q, Wang B, Pang L, Wang Y, Zheng M, Wang Q, et al. Application of citrate as a tricarboxylic acid (TCA) cycle intermediate, prevents diabetic-induced heart damages in mice. Iran J Basic Med Sci. 2016;19:43-8 pubmed
  11. Koussounadis A, Langdon S, Um I, Kay C, Francis K, Harrison D, et al. Dynamic modulation of phosphoprotein expression in ovarian cancer xenograft models. BMC Cancer. 2016;16:205 pubmed 出版商
  12. Pavon M, Arroyo Solera I, Tellez Gabriel M, Leon X, Virós D, Lopez M, et al. Enhanced cell migration and apoptosis resistance may underlie the association between high SERPINE1 expression and poor outcome in head and neck carcinoma patients. Oncotarget. 2015;6:29016-33 pubmed 出版商
  13. Huna A, Salmina K, Erenpreisa J, Vazquez Martin A, Krigerts J, Inashkina I, et al. Role of stress-activated OCT4A in the cell fate decisions of embryonal carcinoma cells treated with etoposide. Cell Cycle. 2015;14:2969-84 pubmed 出版商
  14. Carthy J, Sundqvist A, Heldin A, van Dam H, Kletsas D, Heldin C, et al. Tamoxifen Inhibits TGF-β-Mediated Activation of Myofibroblasts by Blocking Non-Smad Signaling Through ERK1/2. J Cell Physiol. 2015;230:3084-92 pubmed 出版商
  15. Rojas Fernandez A, Herhaus L, MacArtney T, Lachaud C, Hay R, Sapkota G. Rapid generation of endogenously driven transcriptional reporters in cells through CRISPR/Cas9. Sci Rep. 2015;5:9811 pubmed 出版商
  16. Liu X, Chen Z, Xu C, Leng X, Cao H, Ouyang G, et al. Repression of hypoxia-inducible factor α signaling by Set7-mediated methylation. Nucleic Acids Res. 2015;43:5081-98 pubmed 出版商
  17. Zhang W, Pei Y, Zhong L, Wen B, Cao S, Han J. Pluripotent and Metabolic Features of Two Types of Porcine iPSCs Derived from Defined Mouse and Human ES Cell Culture Conditions. PLoS ONE. 2015;10:e0124562 pubmed 出版商
  18. Klein W, Westendorf C, Schmidt A, Conill Cortés M, Rutz C, Blohs M, et al. Defining a conformational consensus motif in cotransin-sensitive signal sequences: a proteomic and site-directed mutagenesis study. PLoS ONE. 2015;10:e0120886 pubmed 出版商
  19. Falkenberg N, Anastasov N, Schaub A, Radulovic V, Schmitt M, Magdolen V, et al. Secreted uPAR isoform 2 (uPAR7b) is a novel direct target of miR-221. Oncotarget. 2015;6:8103-14 pubmed
  20. Li C, Zhu H, Bai W, Su L, Liu J, Cai W, et al. MiR-10a and miR-181c regulate collagen type I generation in hypertrophic scars by targeting PAI-1 and uPA. FEBS Lett. 2015;589:380-9 pubmed 出版商
  21. Huang W, Li L, Tian X, Yan J, Yang X, Wang X, et al. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway. Mol Med Rep. 2015;11:2569-77 pubmed 出版商
  22. Sato M, Kadota M, Tang B, Yang H, Yang Y, Shan M, et al. An integrated genomic approach identifies persistent tumor suppressive effects of transforming growth factor-? in human breast cancer. Breast Cancer Res. 2014;16:R57 pubmed 出版商
  23. Tian L, Zhang L, Liu J, Guo T, Gao C, Ni J. Effects of TSH on the function of human umbilical vein endothelial cells. J Mol Endocrinol. 2014;52:215-22 pubmed 出版商
  24. Feng Y, Wu H, Xu Y, Zhang Z, Liu T, Lin X, et al. Zinc finger protein 451 is a novel Smad corepressor in transforming growth factor-? signaling. J Biol Chem. 2014;289:2072-83 pubmed 出版商
  25. Sharma A, Diecke S, Zhang W, Lan F, He C, Mordwinkin N, et al. The role of SIRT6 protein in aging and reprogramming of human induced pluripotent stem cells. J Biol Chem. 2013;288:18439-47 pubmed 出版商
  26. Popnikolov N, Dalwadi B, Thomas J, Johannes G, Imagawa W. Association of autotaxin and lysophosphatidic acid receptor 3 with aggressiveness of human breast carcinoma. Tumour Biol. 2012;33:2237-43 pubmed 出版商